ABSTRACT
To (J Clin Endocrinol Metab 81: 3733-3739, 1996) T HE ETIOLOGY of Graves' ophthalmopathy (GO) and pretibial dermopathy (PTD) and the reasons for the preferential involvement of the retroorbital and pretibial space are poorly understood (l-5) . During the active stages of GO, infiltration of the retroorbital tissue by mononuclear cells is frequently observed (1, 2). The cellular infiltrate within the retroorbital tissues in GO consists mainly of T lymphocytes, macrophages, and, to a lesser extent, B cells and natural killer cells (6) (7) (8) . The T cell component includes both CD4+ and CD8+ T lymphocytes, many of which express CD45R0, suggesting that they are major histocompatibility complex (MHC) class I and II restricted memory T cells (8) (9) (10) . PTD occurs in a small proportion of patients with Graves' disease (GD), most of whom have ophthalmopathy and high serum titers of TSH receptor-directed antibodies (3-5). Both processes are likely to be driven by T cells that access and infiltrate the retroorbital and pretibial space via certain adhesion molecules and release various cytokines capable of stimulating cell proliferation, GAG synthesis, and the expression of immunomodulatory molecules in microvascular endothelial cells and fibroblasts (1, 2, 10-13). In support of this concept, retroorbital and pretibial fibroblasts have recently been shown to act as targets of the autoimmune process in GO and PTD (14) . However, although these mechanisms may be sufficient to explain certain aspects of how GO and PTD may evolve and be propagated, the primary antigen for these presumed autoimmune manifestations has remained elusive. The close clinical association between the hyperthyroidism of GD, GO, and PTD suggests that the antigen responsible for these diverse conditions may be shared by the thyroid gland and extrathyroidal tissues (11). T cells specifically recognize processed antigens in conjunction with MHC molecules through their T cell receptors (TcR) which consist mostly of (Y-and p-chain heterodimers. The TcR a-chain consists of variable (V), joining (J), and constant (C) regions, whereas the p-chain consists of V, diversity (D), joining, and constant regions. They are designated Va!, JCX, and Ca or VP, Dp, Jp, and C/3, respectively. The antigen specificity of the TcR is defined by the V domains encoded by V, D, and J gene elements that are rearranged and joined during T cell differentiation. 
Results

Immunoperoxidase detection of TcR chains
Immunohistochemistry of sections derived from thyroid, retroorbital, and pretibial tissue samples of both patients revealed the presence of CD3+ T cells. The vast majority of T lymphocytes (-96-98%) were a/ p' T cells, as determined by positive immunoreactivity with a P-chain-specific human TcR antibody (data not shown). Except for occasional cells immunoreactive with the human TcR &chain-specific monoclonal antibody, y6+ T cells were not detected in thyroid, retroorbital, and pretibial specimens of either patient.
T cell antigen receptor V gene analysis
Expression of a broad spectrum of TcR Vol and V/3 genes was detected in cDNA samples prepared from PBL of either patient ( Fig. 1 ; l:B and 2:B) and two control individuals (data not shown). In these samples, between 19-20 Va genes and between 20-22 VP genes, respectively, were actively transcribed. Compared with PBL, restriction of TcR Va and TcR VP genes (<50% of individual genes rearranged and expressed) was detected in thyroid (7 of 22 Va! gene families; 10 of 23 V/3 gene families), retroorbital (9 of 22 Vcr gene families; 10 of 23 VP gene families), and pretibial(8 of 22 Va gene families; 9 of 23 V/3 gene families) tissue obtained from patient 1 (Fig. 1) . Similarly, marked restriction of TcR V~Y and TcR VP genes was detected in retroorbital (8 of 22 Va gene families; 8 of 23 VP gene families) and pretibial (8 of 22 Va gene families; 8 of 23 VP gene families) tissue obtained from patient 2 (Fig. 1) . The presence of dominant TcR VP2 and V/36 gene products in thyroid, orbital, and pretibial tissue of patient 1 and in orbital and pretibial tissue of patient 2 was further confirmed by immunohistochemical staining using monoclonal antibodies directed against human TcR VP2 and TcR V/36 gene families, respectively (Fig. 2) . Further, unrestricted TcR Va or V/3 gene usage was detected in samples derived from the thyroid gland of two control individuals. TcR V gene analysis of retroorbital and pretibial specimens derived from these two control individuals failed to yield TcR-specific transcripts (not shown).
Despite obvious heterogeneity of the TcR V gene repertoire between patients 1 and 2, marked similarities of restricted Va and VP gene family usage were noted in T cells infiltrating the thyroid gland, retroorbital connective tissue, and pretibial skin of either patient. For example, the presence of Va2, Va3, V&3, VaI2, Va15, Va21, Vp2, V/34, Vp6, Vp7, Vp12, Vp20, and VP24 transcripts, was shared by thyroid, retroorbital, and pretibial tissue of patient 1. Further, Vcr3, Va8, VaI2, V(~l4, Va19, Vp2, Vp4, V/36, V/312, VPIS, and VP23 transcripts were present in both retroorbital and pretibial tissue obtained from patient 2.
DNA sequencing was used to determine the amino acid sequences of dominant TcR V gene families that contributed 20% or more of the total VP gene activity detected at individual sites. TcRs using VP6 (patient 1) and VP2 (patient 2) genes, respectively, were amplified by PCR and ligated into pCR II T/A cloning vector. Multiple TcRs were then isolated from these libraries and sequenced. The results of this analysis are summarized in Table 1 . Overexpressed VP2 and V/36 gene families from thyroid, orbital, and pretibial tissues of patients 1 and 2, respectively, revealed major populations of clonally expanded TcRs or TcRs whose rearrangements shared significant homologies at the amino acid level of junctional regions. As demonstrated by sequence analysis of 51 VP6 TcR cDNA clones derived from the involved tissue sites (thyroid, orbit, and pretibium) of patient 1 and of 29 V/32 TcR cDNA clones from the orbit and pretibium of patient 2, single TcR rearrangements accounted for up to 53% (intrathyroidal TcRs in patient 1) of a given TcR family. One TcR clone using V/36.2 (V/36.2-JP2.1) was detected in thyroidal, orbital, and pretibial tissue of patient 1. In addition, a restricted number of J/3 gene family members was detected in distinct tissue sites of either patient. Of the 13 Jp gene family members, only 4 (Jp1.6, -2.1, -2.2, and -2.3) were used by intrathyroidal, orbital, and pretibial TcR V/36 clones in patient 1, and 5 (Jp 1.5, -2.1, -2.2, -2.3, and 2.7) were preferentially used by orbital and pretibial TcR VP2 clones in patient 2. Further, comparison of the CDR3 domains of junctional regions in expanded VP TcR revealed several conserved amino acid motifs that were shared by intrathyroidal, orbital, and pretibial lymphocytes in either patient (Table 1) . In V/36 TcRs of patient 1, the motif G-L-A was used by the dominant intrathyroidal clonotype, and by one of the clonally expanded V/36 orbital and pretibial TcRs, respectively. Similarly, in patient 2, the motifs E-R-G and G-Q-E-L were shared by clonally expanded VP2 orbital and pretibia1 TcRs, respectively. In contrast, none of the dominant rearrangements was found among VP2 and V/36 TcR cloned from PBL from either patient. These results indicate that certain populations of intrathyroidal, orbital, and pretibial lymphocytes in these 2 patients were oligoclonal, and that several clones were present at a high frequency in these distinct sites.
Discussion
T lymphocytes are thought to play a crucial role in the pathogenesis of GD, GO, and PTD (1, 2, 10, 24, 25 identified (10). In a recent study, CD8+ CD45RO+ orbitinfiltrating T lymphocytes from patients with GO were demonstrated to selectively recognize autologous fibroblasts derived from retroocular connective tissue and, to a lesser degree, other anatomical locations (14). These results support the concept that connective tissue fibroblasts represent major targets for T cells that infiltrate the extrathyroidal manifestations associated with GD (26). Recent data from several laboratories have demonstrated TcR V gene restriction in both animal models and human autoimmune diseases, supporting a central role for T cells in the initiation and propagation of autoimmunity (17) (18) (19) (20) . In support of this concept, evidence of limited variability of intrathyroidal TcR V genes in GD has been demonstrated (21-23), although conflicting results have also been reported (27, 28). We have recently detected restriction of TcR V gene usage in retroorbital connective tissue of patients with active GO of recent onset, whereas TcR V gene usage was unrestricted in patients with long standing, inactive GO (24). In addition, analysis of T cell surface markers and TcRs expressed by lymphocytes infiltrating the pretibial space of patients with clinically active PTD revealed a predominance of CD3+ T lymphocytes, many of which are CD@ T cells and express TcR (Y / p-chains (25). Marked restriction of TcR Va and VP gene usage was demonstrated in lymphocytes infiltrating the pretibial tissue of patients with early active PTD, whereas greater diversity of VP gene usage and loss of Vo gene restriction were observed in patients with long standing pretibial dermopathy (25). These results suggested that the primary target antigen in GO and PTD may initiate a restricted T cell V gene response, and that later in the natural history of the disease, tissue destruction and cytokine-induced antigen expression may promote the recruitment of a more diverse spectrum of T cells that use multiple TcR V gene families, and react to a variety of tissue-specific and tissue-nonspecific antigens (29). We hypothesized that among the inflammatory cells infiltrating thyroid, retroorbital, and pretibial tissues of individual patients with GD, subpopulations of autoantigenreactive T cells may be responsible for initiating and perpetuating the immune process. To identify such diseaseassociated T cells, we have analyzed the patterns of TcR-ap gene expression and sequenced the junctional regions of dominating TcR VP genes in thyroid, retroorbital, and pretibial tissue samples derived from two patients with GD, GO and PTD. Although the spectrum of actively transcribed TcR Va and V/3 genes varied among the various samples derived from either patient, several striking features were noted. Marked restriction of the TcR V gene repertoire and overexpression of certain TcR V gene segments were detected in lymphocytes infiltrating thyroid, orbital, and pretibial skin. Heterogeneity of TcR V gene usage may be explained by the fact that the TcR recognizes similar antigenie peptides in the context of HLA molecules, which were different in the two patients studied. Individual HLA gene endowment may play an important role in shaping the TcR V gene repertoire (30, 31) , and this may influence TcR V gene usage in lymphocytes capable of recognizing common antigenie epitopes presented at distinct involved sites in GD. Given the marked similarity in individual TcR V genes expressed by lymphocytes infiltrating distinct anatomical sites, our results suggest that infiltrating T cells might recognize a limited range of antigenic epitopes shared by the thyroid gland, retroorbital connective tissue, and pretibial skin. Furthermore, our data indicate that analogous mechanisms may act to control T cell selection and expansion within both the thyroid gland and the involved extrathyroidal compartments.
To define further the significance of dominating V/32 and VP6 gene families in thyroid, retroorbital, and pretibial tissue of patients 1 and 2, we next examined the clonotypic heterogeneity of these T cells. Sequence analysis of the junctional regions of V/36 and V/32 genes revealed a limited number of independently rearranged TcR p-chain genes, the presence of conserved amino acid residues within the CDR3 region, and selective usage of related J/I gene family members by V/36+ and V/32" T cells infiltrating distinct tissues in the two patients studied. By contrast, limited clonotypic heterogeneity and biased JP gene usage were not detected among patients' PBL or in tissue controls obtained from healthy individuals. The CDR3 region is commonly associated with fine antigenic specificity, and TcRs selected by defined antigenic peptides often show homologous amino acid motifs in the junctional region (16). Accordingly, detection of conserved CDR3 motifs in clonally expanded TcR from distinct anatomical sites is consistent with T cell activation by antigens bearing shared antigenic determinants. Given the similarity of certain HLA alleles in the two patients studied, detection of conserved junctional motifs may reflect the influence of common HLA alleles on TcR selection. The presence of conserved junctional CDR3 motifs joined to different V/3 segments has been reported in several HLA class I-restricted T cell lines and T cell clones specific for the same peptide/MHC complex or in tissues affected by autoimmune conditions, such as giant cell arteritis (32, 33) . Thus, homologous junctional regions appear to confer specificity for the same antigenic determinant even if associated with different V/3 segments. Our detection of a limited number of independently rearranged TcR p-chain genes together with selective usage of related TcR JP gene family members by VP2 and V/36 T cells infiltrating thyroid, retroorbital, and pretibial tissues suggest clonal restriction of these cells, perhaps in response to local stimulation by one or a limited number of antigenic determinants present in these distinct anatomical locations. Although the significance of this apparent bias remains unclear, it is interesting to speculate that the Vp6.2-Jp2.1 clonotype may define a distinct antigenic reactivity, perhaps unique to patient 1. It is likely that Vp2-and V/36-positive T cells proliferate due to antigen-driven stimulation through MHC-antigen-TCR complexes, although the possibility that these cells proliferate in response to a superantigen must be considered.
Involvement of VP2+ and Vp6' T lymphocytes has been observed in several other immune responses affecting gut (34, 35), muscle (36), and skin (37, 38). Clonally expanded VP6+ T cells appear to confer protective immunity to Mycobacterium leprae (39), and V/32+ and Vp6+ T lymphocytes have been attributed antitumor activity against squamous cell carcinomas (40). In addition, V/32 and VP6 TcRs are highly expressed in the intestinal mucosa (35). In GD and its associated extrathyroidal manifestations, recent evidence suggests that the immune response may be directed against certain antigenic determinants that are present in epithelial (thyroid, skin, and orbit) and mucosal (lacrimal gland) tissue components (41, 42). Thus, in view of our previous and current data, and the proposed functions of V/32 and V/36 TcRs in conveying immunosurveillance over mucosal and epithelial surfaces, the role of VP2 and VP6 TcRs in GD warrants further study.
Although the antigens to which T cells infiltrating thyroid, retroorbital, and pretibial tissue in patients with GD respond are unknown, delineation of antigenic reactivities associated with tissue-infiltrating T lymphocytes of patients with GD may help to clarify the significance of the TcR restrictions identified in this study. Analysis of ligands, including selfantigens and HLA alleles, that are recognized by restricted autoreactive T cells should shed light on the mechanisms involved in the evolution of the extrathyroidal manifestations of GD. Thus, if the recurrent character of TcR rearrangements in T cells infiltrating the involved tissues could be confirmed in a larger number of patients with GD who share certain HLA alleles, this approach might ultimately provide a basis for targeted immunotherapy in patients with thyroidal and extrathyroidal manifestations of GD.
In conclusion, we have demonstrated restriction of TcR Va and V/3 gene usage and overexpression of certain dominating TcR Va and VP gene families in thyroid, retroorbital, and pretibial tissue of two patients with GD. Furthermore, detection of TcR oligoclonality and marked homology of TcR V genes rearranged and expressed by T cells infiltrating into these anatomically distinct tissues indicate that similar mechanisms may act to locally control T cell recruitment and expansion within thyroid, orbital, and pretibial tissues in GD. These similarities may be considered molecular evidence that some of the clonally expanded intrathyroidal T cells were strongly selected. Thus, our data are consistent with the hypothesis that in GD, common antigenic determinants may drive the immune response against the thyroid gland and certain extrathyroidal sites. Although the nature of the antigen and the mechanisms leading to its recognition by the immune system await further study, the expression of certain antigenic epitopes by a cell type common to the thyroid gland and the affected extrathyroidal tissues remains a strong possibility. 
